| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycopro... |
|---|---|
| CBN | cannabinol; central benign neoplasm; Commission on Biological Nomenclature |
| FMN | first malignant neoplasm; flavin mononucleotide; frontomaxillonasal [suture] |
| GENPS | genital neoplasm-papilloma syndrome |
| MRN | malignant renal neoplasm |
| neoplasm metastasis | The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. The ability to metastasize is characteristic of all malignant neoplasms. (12 Dec 1998) |
|---|---|
| neoplasm recurrence, local | The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. (12 Dec 1998) |
| neoplasm regression, spontaneous | Disappearance of a neoplasm or neoplastic state without the intervention of therapy. (12 Dec 1998) |
| neoplasm, residual | Remnant of a tumour or cancer after primary, potentially curative therapy. (dr. Daniel masys, written communication) (12 Dec 1998) |
| neoplasm seeding | The local implantation of tumour cells by contamination of instruments and surgical equipment during and after surgical resection, resulting in local growth of the cells and tumour formation. (12 Dec 1998) |
| neoplasm staging | Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. (12 Dec 1998) |
| neoplasm transplantation | Experimental transplantation of neoplasms in laboratory animals for research purposes. (12 Dec 1998) |
| DNA, neoplasm | DNA present in neoplastic tissue. (12 Dec 1998) |
| drug resistance, neoplasm | Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures. (12 Dec 1998) |
| antibody-coated bacteria test, urinary | Fluorescent antibody technique for visualizing antibody-bacteria complexes in urine. The presence or absence of antibody-coated bacteria in urine correlates with localization of urinary tract infection in the kidney or bladder, respectively. (12 Dec 1998) |
| anti-infective agents, urinary | Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (12 Dec 1998) |
| apex of urinary bladder | The junction of the superior and anteroinferior surfaces of the bladder, continuous above with the median umbilical ligament. Synonym: apex vesicae. (05 Mar 2000) |
| blood, urinary | Medically called haematuria, blood in the urine can be microscopic or gross. Evaluating haematuria requires consideration of the entire urinary tract. Tests used for the diagnosis of haematuria include the intravenous pyelogram (IVP), cystoscopy, and urine cytology. Management of haematuria depends upon the underlying cause. (12 Dec 1998) |
| body of urinary bladder | The portion of the bladder between the apex and fundus. Synonym: corpus vesicae urinariae. (05 Mar 2000) |
| reproductive and urinary physiology | Physiology of the human and animal body, male or female, in the reproductive process and the physiology of the urinary tract. (12 Dec 1998) |